Video scenes shots:
Watch the video:
Other videos by this author:
 |
Novel drug formulations for breast cancer already available out there! EBCC 2012 review 5 Posted by: ESMOchannel
Video duration: 119 seconds Prof Zielinski reviews some of the latest available drugs successfully used to treat breast cancer. ESMO reports from the European Breast Cancer Conference 2012. http://www.esmo.org |
 |
Treatment resistance and metastasis development in breast cancer: EBCC 2012 review Posted by: ESMOchannel
Video duration: 158 seconds Prof Zielinski reviews latest research on possible explanations for treatment resistance and how metastasis develop based on the expression of molecular profiles, the interaction with the tumor microenvironment and the tumor host. ESMO reports from the European Breast Cancer Conference 2012. http://www.esmo.org |
 |
Breast cancer and social issues: EBCC 2012 review Posted by: ESMOchannel
Video duration: 94 seconds Prof Zielinski reports on data about the influence of obesity on breast cancer treatment outcome and calls for doctors to be ready to answer patient questions with evidence-based information. ESMO reports from the European Breast Cancer Conference 2012. http://www.esmo.org |
 |
Age still discriminatory when treating women with breast cancer? EBCC 2012 review Posted by: ESMOchannel
Video duration: 204 seconds Prof Zielinski highlights the need to guarantee optimal breast cancer treatment irrespective of the patient's age as well as the influence of pregnancy after cancer. ESMO reports from the European Breast Cancer Conference 2012. http://www.esmo.org |
 |
How society and medical professionals should deal with breast cancer patients: EBCC 2012 review Posted by: ESMOchannel
Video duration: 107 seconds Prof Zielinski reviews important discussions highlighting the need for a truly specialized multidisciplinary approach. ESMO reports from the European Breast Cancer Conference 2012. http://www.esmo.org |
 |
Welcome to ESMO 2012! Posted by: ESMOchannel
Video duration: 61 seconds A welcome message from local host, Christoph Zielinski, about the European Society for Medical Oncology (ESMO) Congress 2012 in Vienna. Not registered yet for this year's top event in medical oncology? You have until 27 June to benefit from the early registration fee http://www.esmo.org/ events/vienna-2012-c ongress |
 |
Possible strategies to attack triple negative breast cancer - IMPAKT 2012 Breast Cancer Conference Posted by: ESMOchannel
Video duration: 265 seconds Dr Di Leo explains why triple negative breast cancer is a difficult heterogeneous disease and which are potential new promising approaches. ESMO reports from IMPAKT 2012. http://www.esmo.org |
 |
Challenges posed by intratumor heterogeneity - IMPAKT 2012 Breast Cancer Conference Posted by: ESMOchannel
Video duration: 343 seconds Prof. Swanton offers a clear-cut picture of the challenges and opportunities offered by improved knowledge of intratumor heterogeneity. ESMO reports from the IMPAKT 2012 Breast Cancer Conference. http://www.esmo.org |
 |
Molecular pathology, the roots of personalized medicine beyond a microscope - IMPAKT 2012 Posted by: ESMOchannel
Video duration: 348 seconds Prof Reis-Filho explores the latest high throughput technology results in molecular pathology to improve treatment for cancer patients. ESMO reports from the IMPAKT 2012 breast cancer conference. http://www.esmo.org |
 |
Genomic signatures in clinical practice - IMPAKT 2012 Posted by: ESMOchannel
Video duration: 202 seconds Experts clarify and give objective recommendations on the use of genomic signature tests. ESMO previews what to expect at the IMPAKT 2012 Breast Cancer Conference. http://www.esmo.org |
 |
IMPAKT 2012 Breast Cancer Conference Highlights Posted by: ESMOchannel
Video duration: 170 seconds Conference co-chairs highlight the latest and hottest topics at the IMPAKT Breast Cancer Conference. ESMO reports on what's in store for researchers, clinicians and pathologists. http://www.esmo.org |
 |
ELCC 2012, the place to be for multidisciplinary interactive discussions in lung cancer Posted by: ESMOchannel
Video duration: 338 seconds The 3rd European Lung Cancer Conference: insight from the Co-Chairs. Organized by top academic experts in lung cancer and thoracic malignancies, this is THE thoracic CME Conference to attend. Lung cancer specialists from a wide range of disciplines share information on the latest developments in basic, clinical and translational research. http://www.esmo.org |
 |
Martine Piccart, My Priorities as ESMO President Posted by: ESMOchannel
Video duration: 325 seconds Interview with Martine Piccart on working together to identify ESMO's priorities for the next 2-4 years. http://www.esmo.org< br /> "We need to know what ESMO can do for you and how we can help you improve your practice." Interested in joining ESMO? Find out more here: http://www.esmo.org/ membership/join-esmo .html |
 |
Lung cancer is a life-changing experience, for patients and oncologists Posted by: ESMOchannel
Video duration: 423 seconds ESMO interviews Raffaele Califano, The Christie NHS Foundation Trust, on the key challenges of treating lung cancer patients versus the big rewards offered by new available therapies. http://www.esmo.org |
 |
Scientific societies: an opportunity for young oncologists to grow Posted by: ESMOchannel
Video duration: 230 seconds Interview with Massimo Di Maio on the importance of educational and networking opportunities by national and international societies: the ESMO-AIOM partnership sustains young oncologists! http://www.esmo.org |
 |
ESMO Young Oncologists Committee: an experience strongly recommended Posted by: ESMOchannel
Video duration: 117 seconds ESMO interviews with Raffaele Califano on the importance for young oncologists to be part of a pan-European network to boost their career and improve their daily practice. http://www.esmo.org |
 |
IMPAKT 2012 Executive Chair Invitation Posted by: ESMOchannel
Video duration: 35 seconds Invitation from the IMPAKT 2012 Executive Chair Sherene Loi: hope to see you there! |
 |
Towards ESMO Congress 2012: a path for medical oncology innovation, not to be missed! Posted by: ESMOchannel
Video duration: 335 seconds Interview with Dr Josep Tabernero, ESMO 2012 Scientific Chair, offering an interesting perspective on what we can expect from the ESMO 2012 Congress. Find out more about ESMO 2012 here: http://www.esmo.org/ events/vienna-2012-c ongress.html Interview by the European Society for Medical Oncology. |
 |
Advanced Breast Cancer - European Multidisciplinary Cancer Congress 2011 Posted by: ESMOchannel
Video duration: 380 seconds ESMO interviews Fabrice André, MD, PhD: an independent expert comment on the impact of the ph-III BOLERO-2 study and a perspective on clinical practice consequences for patients with hormone refractory advanced breast cancer. http://www.esmo.org< br /> Interview by the European Society for Medical Oncology. |
 |
Mesothelioma - European Multidisciplinary Cancer Congress 2011 Posted by: ESMOchannel
Video duration: 324 seconds ESMO interviews Fortunato Ciardiello, MD, PhD about the use of Vorinostat in patients with advanced pleural mesothelioma (VANTAGE 014): urgent need to identify new drugs to face peak of cases in 10 years. http://www.esmo.org< br /> Interview by the European Society for Medical Oncology. |
 |
Colorectal Cancer - European Multidisciplinary Cancer Congress 2011 Posted by: ESMOchannel
Video duration: 350 seconds ESMO interviews Alberto Sobrero, MD, PhD about the results of a phase III study of aflibercept versus placebo in combination with Folfiri for the treatment of patients with previously-treated metastatic colorectal cancer (VELOUR). http://www.esmo.org< br /> Interview by the European Society for Medical Oncology. |
